Viewing Study NCT04466150


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2025-12-25 @ 2:35 PM
Study NCT ID: NCT04466150
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-08
First Post: 2020-07-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
Sponsor: University of California, San Francisco
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module